Effectiveness of COVID-19 Vaccine in Hematopoietic Stem Cell Transplant Patients

NCT05185817 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic Stem Cell Transplantation (HSCT)
COVID-19 Vaccines
Immune System Tolerance

Interventions

BIOLOGICAL: Pasocovac vaccine

Sponsor

Tehran University of Medical Sciences